NCT05013671

Brief Summary

BPPV is a benign condition of the balance organ, localized in the inner ear, in which calcium crystals loosen up and move freely in the endolymphatic fluid of the inner ear (more specifically in the semi-circular canals). During certain posture changes or head movements, these moving calcium crystals cause dizziness and balance problems. The general objective of the study is to evaluate the impact of BPPV on the balance of older adults in nursing homes. For this purpose, we will compare the balance of residents with BPPV with residents without BPPV. Furthermore, we will identify the impact of treatment on balance problems and fall risk in older adults in nursing homes.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
100

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Oct 2020

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 17, 2020

Completed
28 days until next milestone

Study Start

First participant enrolled

October 15, 2020

Completed
10 months until next milestone

First Posted

Study publicly available on registry

August 19, 2021

Completed
1.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2022

Completed
Last Updated

August 19, 2021

Status Verified

August 1, 2021

Enrollment Period

2.2 years

First QC Date

September 17, 2020

Last Update Submit

August 18, 2021

Conditions

Keywords

Benign Paroxysmal Positional Vertigovertigoolder adultsfrailtynursing home

Outcome Measures

Primary Outcomes (40)

  • The presence of BPPV

    This will be measured using the side lying test (posterior and anterior canal BPPV) and the side lying test for horizontal canal BPPV.

    Baseline

  • The presence of BPPV

    This will be measured using the side lying test (posterior and anterior canal BPPV) and the side lying test for horizontal canal BPPV.

    Month 1

  • The presence of BPPV

    This will be measured using the side lying test (posterior and anterior canal BPPV) and the side lying test for horizontal canal BPPV.

    Month 3

  • The presence of BPPV

    This will be measured using the side lying test (posterior and anterior canal BPPV) and the side lying test for horizontal canal BPPV.

    Month 6

  • The presence of BPPV

    This will be measured using the side lying test (posterior and anterior canal BPPV) and the side lying test for horizontal canal BPPV.

    Month 12

  • Dizziness Handicap Inventory

    Self-reported impact of dizziness on daily life. There is a maximum score of 100 (28 points for physical, 36 points for emotional and 36 points for functional) and a minimum score of 0. The higher score, the greater the perceived handicap due to dizziness.

    Baseline

  • Dizziness Handicap Inventory

    Self-reported impact of dizziness on daily life. There is a maximum score of 100 (28 points for physical, 36 points for emotional and 36 points for functional) and a minimum score of 0. The higher score, the greater the perceived handicap due to dizziness.

    Month 1

  • Dizziness Handicap Inventory

    Self-reported impact of dizziness on daily life. There is a maximum score of 100 (28 points for physical, 36 points for emotional and 36 points for functional) and a minimum score of 0. The higher score, the greater the perceived handicap due to dizziness.

    Month 3

  • Dizziness Handicap Inventory

    Self-reported impact of dizziness on daily life. There is a maximum score of 100 (28 points for physical, 36 points for emotional and 36 points for functional) and a minimum score of 0. The higher score, the greater the perceived handicap due to dizziness.

    Month 6

  • Dizziness Handicap Inventory

    Self-reported impact of dizziness on daily life. There is a maximum score of 100 (28 points for physical, 36 points for emotional and 36 points for functional) and a minimum score of 0. The higher score, the greater the perceived handicap due to dizziness.

    Month 12

  • Falls Efficacy Scale International

    Measuring fear of falling during daily and social activities. There is a minimum score of 16 (no concern about falling) to maximum 64 (severe concern about falling).

    Baseline

  • Falls Efficacy Scale International

    Measuring fear of falling during daily and social activities. There is a minimum score of 16 (no concern about falling) to maximum 64 (severe concern about falling).

    Month 1

  • Falls Efficacy Scale International

    Measuring fear of falling during daily and social activities. There is a minimum score of 16 (no concern about falling) to maximum 64 (severe concern about falling).

    Month 3

  • Falls Efficacy Scale International

    Measuring fear of falling during daily and social activities. There is a minimum score of 16 (no concern about falling) to maximum 64 (severe concern about falling).

    Month 6

  • Falls Efficacy Scale International

    Measuring fear of falling during daily and social activities. There is a minimum score of 16 (no concern about falling) to maximum 64 (severe concern about falling).

    Month 12

  • Static balance

    Measuring balance in four positions: stand straight with eyes open (firm surface), standing straight with eyes closed (firm surface), standing straight on a foam with eyes open and standing straight on a foam with eyes closed.

    Baseline

  • Static balance

    Measuring balance in four positions: stand straight with eyes open (firm surface), standing straight with eyes closed (firm surface), standing straight on a foam with eyes open and standing straight on a foam with eyes closed.

    Month 1

  • Static balance

    Measuring balance in four positions: stand straight with eyes open (firm surface), standing straight with eyes closed (firm surface), standing straight on a foam with eyes open and standing straight on a foam with eyes closed.

    Month 3

  • Static balance

    Measuring balance in four positions: stand straight with eyes open (firm surface), standing straight with eyes closed (firm surface), standing straight on a foam with eyes open and standing straight on a foam with eyes closed.

    Month 6

  • Static balance

    Measuring balance in four positions: stand straight with eyes open (firm surface), standing straight with eyes closed (firm surface), standing straight on a foam with eyes open and standing straight on a foam with eyes closed.

    Month 12

  • Timed up and Go (TUG)

    Measuring dynamic balance and gait during TUG over a 3 meter distance

    Baseline

  • Timed up and Go (TUG)

    Measuring dynamic balance and gait during TUG over a 3 meter distance

    Month 1

  • Timed up and Go (TUG)

    Measuring dynamic balance and gait during TUG over a 3 meter distance

    Month 3

  • Timed up and Go (TUG)

    Measuring dynamic balance and gait during TUG over a 3 meter distance

    Month 6

  • Timed up and Go (TUG)

    Measuring dynamic balance and gait during TUG over a 3 meter distance

    Month 12

  • 360° turn

    Measuring dynamic balance during a 360° turn

    Baseline

  • 360° turn

    Measuring dynamic balance during a 360° turn

    month 1

  • 360° turn

    Measuring dynamic balance during a 360° turn

    month 3

  • 360° turn

    Measuring dynamic balance during a 360° turn

    month 6

  • 360° turn

    Measuring dynamic balance during a 360° turn

    month 12

  • 10 meter walk test

    The participant walks 10 meters at a comfortable pace. A walking aid/orthosis can be used during the test, but the help from a third party during is prohibited. Body movements will be registered wuth the use of ADPM sensors.

    Baseline

  • 10 meter walk test

    The participant walks 10 meters at a comfortable pace. A walking aid/orthosis can be used during the test, but the help from a third party during is prohibited. Body movements will be registered wuth the use of ADPM sensors.

    Month 1

  • 10 meter walk test

    The participant walks 10 meters at a comfortable pace. A walking aid/orthosis can be used during the test, but the help from a third party during is prohibited. Body movements will be registered wuth the use of ADPM sensors.

    Month 3

  • 10 meter walk test

    The participant walks 10 meters at a comfortable pace. A walking aid/orthosis can be used during the test, but the help from a third party during is prohibited. Body movements will be registered wuth the use of ADPM sensors.

    Month 6

  • 10 meter walk test

    The participant walks 10 meters at a comfortable pace. A walking aid/orthosis can be used during the test, but the help from a third party during is prohibited. Body movements will be registered wuth the use of ADPM sensors.

    Month 12

  • Knee extensor strength

    The strength of the knee extensor muscles of the right leg will be assessed with hand-held dynamometry (MicroFET). This dynamometer is placed between the leg segment to be evaluated and the examiner's hand. Participants were asked to sit with their legs over the end of a standard, examination table, with hips and knees flexed to 90. Participants have to hold the side-edges of the table with their hands and carry out a maximal isometric voluntary contraction for 3-5 s. The break method will be used to asses the knee extensor strength. This test will be performed 3 times.

    Baseline

  • Knee extensor strength

    The strength of the knee extensor muscles of the right leg will be assessed with hand-held dynamometry (MicroFET). This dynamometer is placed between the leg segment to be evaluated and the examiner's hand. Participants were asked to sit with their legs over the end of a standard, examination table, with hips and knees flexed to 90. Participants have to hold the side-edges of the table with their hands and carry out a maximal isometric voluntary contraction for 3-5 s. The break method will be used to asses the knee extensor strength. This test will be performed 3 times.

    Month 1

  • Knee extensor strength

    The strength of the knee extensor muscles of the right leg will be assessed with hand-held dynamometry (MicroFET). This dynamometer is placed between the leg segment to be evaluated and the examiner's hand. Participants were asked to sit with their legs over the end of a standard, examination table, with hips and knees flexed to 90. Participants have to hold the side-edges of the table with their hands and carry out a maximal isometric voluntary contraction for 3-5 s. The break method will be used to asses the knee extensor strength. This test will be performed 3 times.

    Month 3

  • Knee extensor strength

    The strength of the knee extensor muscles of the right leg will be assessed with hand-held dynamometry (MicroFET). This dynamometer is placed between the leg segment to be evaluated and the examiner's hand. Participants were asked to sit with their legs over the end of a standard, examination table, with hips and knees flexed to 90. Participants have to hold the side-edges of the table with their hands and carry out a maximal isometric voluntary contraction for 3-5 s. The break method will be used to asses the knee extensor strength. This test will be performed 3 times.

    Month 6

  • Knee extensor strength

    The strength of the knee extensor muscles of the right leg will be assessed with hand-held dynamometry (MicroFET). This dynamometer is placed between the leg segment to be evaluated and the examiner's hand. Participants were asked to sit with their legs over the end of a standard, examination table, with hips and knees flexed to 90. Participants have to hold the side-edges of the table with their hands and carry out a maximal isometric voluntary contraction for 3-5 s. The break method will be used to asses the knee extensor strength. This test will be performed 3 times.

    Month 12

Secondary Outcomes (50)

  • Fall incidents

    Baseline

  • Fall incidents

    month 1

  • Fall incidents

    month 3

  • Fall incidents

    month 6

  • Fall incidents

    month 12

  • +45 more secondary outcomes

Study Arms (2)

residents with BPPV

ACTIVE COMPARATOR
Other: repositioning maneuversOther: balance

residents without BPPV

OTHER
Other: balance

Interventions

The calcium crystals floating in the endolymphatic fluid will put back in place by putting the patient in several sitting and lying positions during specific repositioning maneuvers. During these maneuvers the calcium crystals will float from the semicircular canals back into the utriculus, after which the dizziness symptoms should disappear

residents with BPPV
balanceOTHER

compare the balance of residents with BPPV with residents without BPPV

residents with BPPVresidents without BPPV

Eligibility Criteria

Age65 Years+
Sexall
Healthy VolunteersYes
Age GroupsOlder Adult (65+)

You may qualify if:

  • Institutionalized for at least 3 months
  • Willing to participate
  • Able to understand simple instructions
  • Able to stand independently for 10 seconds (with the use of a walking aid)

You may not qualify if:

  • Diagnosis of progressive neurological conditions resulting in a fast deterioration (i.e. amyotrophic lateral sclerosis or residents with palliative care)
  • Participation in a rehabilitation program at the current time for a pathology of less than 6 months
  • Contra-indication for vestibular testing such as heart failure or fear

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

WZC Leopoldspark

Leopoldsburg, 3970, Belgium

RECRUITING

MeSH Terms

Conditions

Benign Paroxysmal Positional VertigoVertigoFrailty

Condition Hierarchy (Ancestors)

Vestibular DiseasesLabyrinth DiseasesEar DiseasesOtorhinolaryngologic DiseasesNeurologic ManifestationsNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and SymptomsPathologic Processes

Study Officials

  • Joke Spildooren, prof. dr.

    Hasselt University

    PRINCIPAL INVESTIGATOR
  • Laura Casters, drs.

    Hasselt University

    STUDY CHAIR

Central Study Contacts

Joke Spildooren, prof. dr.

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
OTHER
Intervention Model
PARALLEL
Model Details: First, the nursing home resident will be assessed for the presence of BPPV. Based on the presence of BPPV, two groups will be formed: BPPV-group and control group. The residents suffering from BPPV will undergo balance tests and will be treated for their BPPV (BPPV-group). The nursing home residents with BPPV will be matched to residents without the disease (case control design) and will also undergo balance tests. At 1,3,6 and 12 months the presence of balance problems will be followed up in both groups.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

September 17, 2020

First Posted

August 19, 2021

Study Start

October 15, 2020

Primary Completion

December 31, 2022

Study Completion

December 31, 2022

Last Updated

August 19, 2021

Record last verified: 2021-08

Locations